GlobeNewswire

Search Results

Organization: (Noven Pharmaceuticals, Inc. OR Novan, Inc.)

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Noven Pharmaceuticals, Inc.

Novan, Inc.

Showing 1-10 of about 54 articles.

Novan, Inc.

Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation

October 16, 2018

Novan, Inc.

Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan

October 08, 2018

Novan, Inc.

Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November

October 01, 2018

Novan, Inc.

Novan Receives FDA Guidance for SB204 and Acne Indication

September 24, 2018

Novan, Inc.

Novan Announces Promising Clinical Results with SB414

August 20, 2018

Novan, Inc.

Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract

August 08, 2018

Novan, Inc.

Novan to Participate in Upcoming Investor Conferences

June 13, 2018

Novan, Inc.

Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 01, 2018

Novan, Inc.

SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment

May 17, 2018

Novan, Inc.

Novan Provides Update on SB414 Inflammatory Skin Disease Development Program

May 15, 2018

Showing 1-10 of about 54 articles.

Organization: (Noven Pharmaceuticals, Inc. OR Novan, Inc.)

Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation

Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan

Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November

Novan Receives FDA Guidance for SB204 and Acne Indication

Novan Announces Promising Clinical Results with SB414

Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract

Novan to Participate in Upcoming Investor Conferences

Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment

Novan Provides Update on SB414 Inflammatory Skin Disease Development Program

Newswire Distribution Network & Management

About Us